_version_ 1785090731545722880
author Palomares, Laida Cuevas
Pérez, Ernesto
Cilaurren, Ariane Unamunzaga
De Ocariz, Xabier Gutierrez Lopez
Ureña, Buenaventura Buendia
Fernández, Carmen Molinillo
Ibarrondo, Begoña Benito
Osua, Ana Cordero
Delgado, Beatriz Benitez
Moralejo, Miguel Andrés
Albás, Juan García
de Castro, Jose Guinea
author_facet Palomares, Laida Cuevas
Pérez, Ernesto
Cilaurren, Ariane Unamunzaga
De Ocariz, Xabier Gutierrez Lopez
Ureña, Buenaventura Buendia
Fernández, Carmen Molinillo
Ibarrondo, Begoña Benito
Osua, Ana Cordero
Delgado, Beatriz Benitez
Moralejo, Miguel Andrés
Albás, Juan García
de Castro, Jose Guinea
author_sort Palomares, Laida Cuevas
collection PubMed
description
format Online
Article
Text
id pubmed-10429504
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104295042023-08-17 PB2701: SAFETY OF 30 MINUTES INFUSION OF RITUXIMAB BIOSIMILAR. A COHORT STUDY. Palomares, Laida Cuevas Pérez, Ernesto Cilaurren, Ariane Unamunzaga De Ocariz, Xabier Gutierrez Lopez Ureña, Buenaventura Buendia Fernández, Carmen Molinillo Ibarrondo, Begoña Benito Osua, Ana Cordero Delgado, Beatriz Benitez Moralejo, Miguel Andrés Albás, Juan García de Castro, Jose Guinea Hemasphere Publication Only Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10429504/ http://dx.doi.org/10.1097/01.HS9.0000977476.10247.9d Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Publication Only
Palomares, Laida Cuevas
Pérez, Ernesto
Cilaurren, Ariane Unamunzaga
De Ocariz, Xabier Gutierrez Lopez
Ureña, Buenaventura Buendia
Fernández, Carmen Molinillo
Ibarrondo, Begoña Benito
Osua, Ana Cordero
Delgado, Beatriz Benitez
Moralejo, Miguel Andrés
Albás, Juan García
de Castro, Jose Guinea
PB2701: SAFETY OF 30 MINUTES INFUSION OF RITUXIMAB BIOSIMILAR. A COHORT STUDY.
title PB2701: SAFETY OF 30 MINUTES INFUSION OF RITUXIMAB BIOSIMILAR. A COHORT STUDY.
title_full PB2701: SAFETY OF 30 MINUTES INFUSION OF RITUXIMAB BIOSIMILAR. A COHORT STUDY.
title_fullStr PB2701: SAFETY OF 30 MINUTES INFUSION OF RITUXIMAB BIOSIMILAR. A COHORT STUDY.
title_full_unstemmed PB2701: SAFETY OF 30 MINUTES INFUSION OF RITUXIMAB BIOSIMILAR. A COHORT STUDY.
title_short PB2701: SAFETY OF 30 MINUTES INFUSION OF RITUXIMAB BIOSIMILAR. A COHORT STUDY.
title_sort pb2701: safety of 30 minutes infusion of rituximab biosimilar. a cohort study.
topic Publication Only
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429504/
http://dx.doi.org/10.1097/01.HS9.0000977476.10247.9d
work_keys_str_mv AT palomareslaidacuevas pb2701safetyof30minutesinfusionofrituximabbiosimilaracohortstudy
AT perezernesto pb2701safetyof30minutesinfusionofrituximabbiosimilaracohortstudy
AT cilaurrenarianeunamunzaga pb2701safetyof30minutesinfusionofrituximabbiosimilaracohortstudy
AT deocarizxabiergutierrezlopez pb2701safetyof30minutesinfusionofrituximabbiosimilaracohortstudy
AT urenabuenaventurabuendia pb2701safetyof30minutesinfusionofrituximabbiosimilaracohortstudy
AT fernandezcarmenmolinillo pb2701safetyof30minutesinfusionofrituximabbiosimilaracohortstudy
AT ibarrondobegonabenito pb2701safetyof30minutesinfusionofrituximabbiosimilaracohortstudy
AT osuaanacordero pb2701safetyof30minutesinfusionofrituximabbiosimilaracohortstudy
AT delgadobeatrizbenitez pb2701safetyof30minutesinfusionofrituximabbiosimilaracohortstudy
AT moralejomiguelandres pb2701safetyof30minutesinfusionofrituximabbiosimilaracohortstudy
AT albasjuangarcia pb2701safetyof30minutesinfusionofrituximabbiosimilaracohortstudy
AT decastrojoseguinea pb2701safetyof30minutesinfusionofrituximabbiosimilaracohortstudy